Eli Lilly And Company Shines In Q2 With $11.30B Revenue, 68% EPS Growth

Eli Lilly and Company has reported a strong financial performance for the second quarter of 2024, with revenue reaching $11.30 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.